Showing 1 - 20 results of 78 for search 'Steven Simoens', query time: 0.06s Refine Results
  1. 1
    Biosimilar medicines and cost-effectiveness

    Biosimilar medicines and cost-effectiveness by Steven Simoens

    Published 2011-02-01
    Get full text
    Article
  2. 2
    Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies

    Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies by Steven Simoens

    Published 2022-10-01
    Get full text
    Article
  3. 3
    Generic and biosimilar medicines: quid?

    Generic and biosimilar medicines: quid? by Steven Simoens

    Published 2012-12-01
    Get full text
    Article
  4. 4
    Health Economics of Antibiotics

    Health Economics of Antibiotics by Steven Simoens

    Published 2010-04-01
    Get full text
    Article
  5. 5
    The cost-effectiveness of prevention: is an ounce of prevention worth a pound of cure?

    The cost-effectiveness of prevention: is an ounce of prevention worth a pound of cure? by Steven Simoens

    Published 2012-03-01
    Get full text
    Article
  6. 6
    Assessment of methodological quality of economic evaluations in belgian drug reimbursement applications.

    Assessment of methodological quality of economic evaluations in belgian drug reimbursement applications. by Steven Simoens

    Published 2013-01-01
    Get full text
    Article
  7. 7
    Emerging Insights into European Markets of Biologics, Including Biosimilars

    Emerging Insights into European Markets of Biologics, Including Biosimilars by Steven Simoens, Isabelle Huys

    Published 2022-05-01
    Get full text
    Article
  8. 8
    Generic Medicine Pricing Policies in Europe: Current Status and Impact

    Generic Medicine Pricing Policies in Europe: Current Status and Impact by Pieter Dylst, Steven Simoens

    Published 2010-03-01
    Get full text
    Article
  9. 9
    R&D Costs of New Medicines: A Landscape Analysis

    R&D Costs of New Medicines: A Landscape Analysis by Steven Simoens, Isabelle Huys

    Published 2021-10-01
    Get full text
    Article
  10. 10
    Tendering and biosimilars: what role for value-added services?

    Tendering and biosimilars: what role for value-added services? by Steven Simoens, Raymond Cheung

    Published 2020-01-01
    Get full text
    Article
  11. 11
    Guidance for Demonstrating the Societal Value of new Antibiotics

    Guidance for Demonstrating the Societal Value of new Antibiotics by Steven Simoens, Isabel Spriet, Isabel Spriet

    Published 2021-02-01
    Get full text
    Article
  12. 12
    Off-label use of orphan medicinal products: a Belgian qualitative study

    Off-label use of orphan medicinal products: a Belgian qualitative study by Marc Dooms, David Cassiman, Steven Simoens

    Published 2016-10-01
    Get full text
    Article
  13. 13
    Simulating Costs of Intravenous Biosimilar Trastuzumab vs. Subcutaneous Reference Trastuzumab in Adjuvant HER2-Positive Breast Cancer: A Belgian Case Study

    Simulating Costs of Intravenous Biosimilar Trastuzumab vs. Subcutaneous Reference Trastuzumab in Adjuvant HER2-Positive Breast Cancer: A Belgian Case Study by Steven Simoens, Arnold G. Vulto, Pieter Dylst

    Published 2021-05-01
    Get full text
    Article
  14. 14
    From generic to biosimilar drugs: why take an innovative pace?

    From generic to biosimilar drugs: why take an innovative pace? by Fereshteh Barei, Claude Le Pen, Steven Simoens

    Published 2012-12-01
    Get full text
    Article
  15. 15
    Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review

    Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review by Khadidja Abdallah, Isabelle Huys, Kathleen Claes, Steven Simoens

    Published 2021-04-01
    Get full text
    Article
  16. 16
    How to Value Orphan Drugs? A Review of European Value Assessment Frameworks

    How to Value Orphan Drugs? A Review of European Value Assessment Frameworks by Alessandra Blonda, Yvonne Denier, Isabelle Huys, Steven Simoens

    Published 2021-05-01
    Get full text
    Article
  17. 17
    What role for real-world evidence in market access of biosimilars?

    What role for real-world evidence in market access of biosimilars? by Steven Simoens, Catherine M. Lockhart, Delphine F. Courmier

    Published 2025-02-01
    Get full text
    Article
  18. 18
    Insights into European drug shortages: a survey of hospital pharmacists.

    Insights into European drug shortages: a survey of hospital pharmacists. by Kim Pauwels, Steven Simoens, Minne Casteels, Isabelle Huys

    Published 2015-01-01
    Get full text
    Article
  19. 19
    A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe

    A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe by Khadidja Abdallah, Kris De Boeck, Marc Dooms, Steven Simoens

    Published 2021-11-01
    Get full text
    Article
  20. 20
    Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries

    Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries by Alessandra Blonda, Teresa Barcina Lacosta, Mondher Toumi, Steven Simoens

    Published 2022-01-01
    Get full text
    Article

Search Tools: